GSA Capital Partners’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$342K Buy
2025
Q1
$119K Buy
2023
Q4
Sell
2023
Q3
$1.1M Buy
2022
Q1
Sell
2021
Q4
$583K Sell
2021
Q3
$1.24M Buy
2021
Q2
$260K Buy